Partner Article

Boardroom shuffle amid soaring sales at IDS

MEDICAL testing firm IDS has announced a 49% surge in sales to £37.16m fuelled by continual demand for its kits which are used to diagnose and monitor diseases.

The South Tyneside business said its gross profit in the year ended 31 March jumped 66% to £27.52m while sales of its manual Vitamin D tests increased 72% to £22m.

Chairman David Evans said: ““Trading for the first three months of the of the year has been in line with management expectations and I feel that the opportunities laid at our feet as a result of having the IDS-iSYS are very exciting and I look forward to updating you throughout the year on its progress.”

Meanwhile IDS today announced that Roger Duggan will step down as CEO in October, remaining on the board as deputy chairman and head of the business development group.

Current COO Ian Cookson will replace Mr Duggan in the chief executive berth and IDS will look to appoint a new operations director to take up the role previously fulfilled by Ian.

IDS employs around 75 people across its sites in Boldon on Tyneside, Germany, the US and Scandinavia.

This was posted in Bdaily's Members' News section by Ruth Mitchell .